Application number | Title of the application | Filing Date | Status |
---|
Array
(
[id] => 2889904
[patent_doc_number] => 05240695
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-08-31
[patent_title] => 'Use of 2-hydroxy-4-methoxybenzophenone-5-sulphonic acid or its salts for protecting the hair against environmental attacking agents, and especially against light and process for protecting the hair using the compound'
[patent_app_type] => 1
[patent_app_number] => 7/962676
[patent_app_country] => US
[patent_app_date] => 1992-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3076
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/240/05240695.pdf
[firstpage_image] =>[orig_patent_app_number] => 962676
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/962676 | Use of 2-hydroxy-4-methoxybenzophenone-5-sulphonic acid or its salts for protecting the hair against environmental attacking agents, and especially against light and process for protecting the hair using the compound | Oct 18, 1992 | Issued |
07/961061 | USE OF A BONE MORPHOGENETIC PROTEIN IN SYNERGISTIC COMBINATION WITH TGF-BETA FOR BONE REPAIR | Oct 13, 1992 | Abandoned |
07/960199 | AGENT FOR TREATING OR PREVENTING AIDS | Oct 8, 1992 | Abandoned |
Array
(
[id] => 3458449
[patent_doc_number] => 05401832
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-03-28
[patent_title] => 'Brain derived and recombinant acidic fibroblast growth factor'
[patent_app_type] => 1
[patent_app_number] => 7/951365
[patent_app_country] => US
[patent_app_date] => 1992-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 12240
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/401/05401832.pdf
[firstpage_image] =>[orig_patent_app_number] => 951365
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/951365 | Brain derived and recombinant acidic fibroblast growth factor | Sep 24, 1992 | Issued |
07/934722 | CURCULIN C | Aug 23, 1992 | Abandoned |
Array
(
[id] => 3034605
[patent_doc_number] => 05300490
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-04-05
[patent_title] => 'Anticoagulant substance obtained from urine'
[patent_app_type] => 1
[patent_app_number] => 7/932559
[patent_app_country] => US
[patent_app_date] => 1992-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6157
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 294
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/300/05300490.pdf
[firstpage_image] =>[orig_patent_app_number] => 932559
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/932559 | Anticoagulant substance obtained from urine | Aug 19, 1992 | Issued |
07/932134 | METHOD FOR INHIBITING HIV REPLICATION USING IL-4 | Aug 18, 1992 | Abandoned |
Array
(
[id] => 3076284
[patent_doc_number] => 05322837
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-06-21
[patent_title] => 'Homogeneous erythropoietin compositions and methods of using same'
[patent_app_type] => 1
[patent_app_number] => 7/903220
[patent_app_country] => US
[patent_app_date] => 1992-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4375
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/322/05322837.pdf
[firstpage_image] =>[orig_patent_app_number] => 903220
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/903220 | Homogeneous erythropoietin compositions and methods of using same | Jul 30, 1992 | Issued |
Array
(
[id] => 3490046
[patent_doc_number] => 05439884
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-08-08
[patent_title] => 'Method of controlling fertilization using bombesin or its agonist'
[patent_app_type] => 1
[patent_app_number] => 7/919731
[patent_app_country] => US
[patent_app_date] => 1992-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 10177
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/439/05439884.pdf
[firstpage_image] =>[orig_patent_app_number] => 919731
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/919731 | Method of controlling fertilization using bombesin or its agonist | Jul 26, 1992 | Issued |
Array
(
[id] => 3425790
[patent_doc_number] => 05416071
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-05-16
[patent_title] => 'Water-soluble composition for sustained-release containing epo and hyaluronic acid'
[patent_app_type] => 1
[patent_app_number] => 7/909160
[patent_app_country] => US
[patent_app_date] => 1992-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 19713
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/416/05416071.pdf
[firstpage_image] =>[orig_patent_app_number] => 909160
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/909160 | Water-soluble composition for sustained-release containing epo and hyaluronic acid | Jul 5, 1992 | Issued |
Array
(
[id] => 2952656
[patent_doc_number] => 05231010
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-07-27
[patent_title] => 'Recombinant aprotinin variants genetically engineered process for the microbial preparation of homogeneously processed aprotinin variants and the therapeutic use thereof'
[patent_app_type] => 1
[patent_app_number] => 7/904246
[patent_app_country] => US
[patent_app_date] => 1992-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 4592
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/231/05231010.pdf
[firstpage_image] =>[orig_patent_app_number] => 904246
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/904246 | Recombinant aprotinin variants genetically engineered process for the microbial preparation of homogeneously processed aprotinin variants and the therapeutic use thereof | Jun 24, 1992 | Issued |
Array
(
[id] => 3007092
[patent_doc_number] => 05374713
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-12-20
[patent_title] => 'Peptide inhibitors of phospholipase A.sub.2 purified from inflammatory sites'
[patent_app_type] => 1
[patent_app_number] => 7/861962
[patent_app_country] => US
[patent_app_date] => 1992-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 1450
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/374/05374713.pdf
[firstpage_image] =>[orig_patent_app_number] => 861962
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/861962 | Peptide inhibitors of phospholipase A.sub.2 purified from inflammatory sites | Jun 17, 1992 | Issued |
07/897135 | PROPHYLAXIS AND TREATMENT OF COAGULATION DISORDERS ASSOCIATED WITH SEPTICEMIA | Jun 10, 1992 | Abandoned |
Array
(
[id] => 3459794
[patent_doc_number] => 05382574
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-01-17
[patent_title] => 'Insulin preparations containing nicotinic acid or nicotinamide'
[patent_app_type] => 1
[patent_app_number] => 7/849448
[patent_app_country] => US
[patent_app_date] => 1992-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2612
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/382/05382574.pdf
[firstpage_image] =>[orig_patent_app_number] => 849448
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/849448 | Insulin preparations containing nicotinic acid or nicotinamide | May 19, 1992 | Issued |
Array
(
[id] => 2881014
[patent_doc_number] => 05268169
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-12-07
[patent_title] => 'Treatment method of ovarian cancer using interferon gamma'
[patent_app_type] => 1
[patent_app_number] => 7/867778
[patent_app_country] => US
[patent_app_date] => 1992-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1276
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/268/05268169.pdf
[firstpage_image] =>[orig_patent_app_number] => 867778
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/867778 | Treatment method of ovarian cancer using interferon gamma | Apr 12, 1992 | Issued |
Array
(
[id] => 2919344
[patent_doc_number] => 05234908
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-08-10
[patent_title] => 'Method of treating gastrointestinal ulcers with platelet derived growth factor'
[patent_app_type] => 1
[patent_app_number] => 7/866822
[patent_app_country] => US
[patent_app_date] => 1992-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4535
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/234/05234908.pdf
[firstpage_image] =>[orig_patent_app_number] => 866822
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/866822 | Method of treating gastrointestinal ulcers with platelet derived growth factor | Apr 9, 1992 | Issued |
07/863251 | PHARMACEUTICAL COMPOSITION OF STABILIZED [LEU 1 3]-MOTILIN-HSE | Apr 2, 1992 | Abandoned |
Array
(
[id] => 2976070
[patent_doc_number] => 05256644
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-10-26
[patent_title] => 'Wound healing using IGF-II and TGF'
[patent_app_type] => 1
[patent_app_number] => 7/857713
[patent_app_country] => US
[patent_app_date] => 1992-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2715
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/256/05256644.pdf
[firstpage_image] =>[orig_patent_app_number] => 857713
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/857713 | Wound healing using IGF-II and TGF | Mar 24, 1992 | Issued |
Array
(
[id] => 3039846
[patent_doc_number] => 05376636
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-12-27
[patent_title] => 'Method for promoting tissue repair and regeneration using PDGF and glucocorticoids'
[patent_app_type] => 1
[patent_app_number] => 7/849931
[patent_app_country] => US
[patent_app_date] => 1992-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 3525
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/376/05376636.pdf
[firstpage_image] =>[orig_patent_app_number] => 849931
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/849931 | Method for promoting tissue repair and regeneration using PDGF and glucocorticoids | Mar 11, 1992 | Issued |
Array
(
[id] => 2970862
[patent_doc_number] => 05258501
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-11-02
[patent_title] => 'Stabilization of glycoproteins'
[patent_app_type] => 1
[patent_app_number] => 7/844826
[patent_app_country] => US
[patent_app_date] => 1992-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 10
[patent_no_of_words] => 6183
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 154
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/258/05258501.pdf
[firstpage_image] =>[orig_patent_app_number] => 844826
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/844826 | Stabilization of glycoproteins | Mar 1, 1992 | Issued |